You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 55 No. 12, December 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (61)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Public Health
 •Substance Abuse/ Alcoholism
 •Alert me on articles by topic

Family History of Alcoholism and Hypothalamic Opioidergic Activity

Gary S. Wand, MD; Deborah Mangold, MA; Samer El Deiry, MD, PhD; Mary E. McCaul, PhD; Donald Hoover, PhD

Arch Gen Psychiatry. 1998;55:1114-1119.

Background  This study was designed to assess whether nonalcoholic offspring from families with a high density of alcohol-dependent individuals have altered endogenous central nervous system opioid activity. Naloxone hydrochloride stimulates plasma cortisol by blocking opioidergic input on the corticotropin-releasing factor neuron, thereby providing a noninvasive method for measuring hypothalamic opioid tone.

Methods  Forty-eight nonalcoholic subjects aged 18 to 25 years were enrolled in a protocol to measure endogenous opioid activity by inducing opioid receptor blockade with the receptor antagonist, naloxone. Twenty-six subjects were offspring from families with a high density of alcohol dependence and were designated as family history–positive subjects. Twenty-two subjects were biological offspring of nonalcohol-dependent parents and designated as family history–negative subjects. Subjects received naloxone hydrochloride (0, 125, and 375 µg/kg) in double-blind, randomized order. Serum cortisol levels were monitored.

Results  Family history–negative subjects had a graded cortisol response to each dose of naloxone. In contrast, family history–positive subjects achieved a maximal cortisol response to the 125-µg/kg dose of naloxone hydrochloride with no further increase in cortisol levels observed following the 375-µg/kg dose. Family history–negative subjects had a diminished cortisol response to the 125-µg/kg dose compared with the family history–positive subjects. Plasma naloxone concentrations did not differ between family history groups.

Conclusions  Individuals from families with a high density of alcohol dependence are more sensitive to naloxone compared with offspring of nonalcohol-dependent parents. This implies that individuals with a family history of alcohol dependence have diminished endogenous hypothalamic opioid activity.


From The Johns Hopkins University School of Medicine (Drs Wand, El Deiry, and McCaul and Ms Mangold) and The Johns Hopkins University School of Public Health (Dr Hoover), Baltimore, Md.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

NEUROCHEMICAL MARKERS OF ALCOHOLISM VULNERABILITY IN HUMANS
Ratsma et al.
Alcohol Alcohol 2002;37:522-533.
ABSTRACT | FULL TEXT  

Role of Protein Kinase C in Control of Ethanol-Modulated beta -Endorphin Release from Hypothalamic Neurons in Primary Cultures
De et al.
J. Pharmacol. Exp. Ther. 2002;301:119-128.
ABSTRACT | FULL TEXT  

PLASMA LEVELS OF BETA-ENDORPHIN, ADRENOCORTICOTROPIC HORMONE AND CORTISOL DURING EARLY AND LATE ALCOHOL WITHDRAWAL
Esel et al.
Alcohol Alcohol 2001;36:572-576.
ABSTRACT | FULL TEXT  

TRAIT MARKERS FOR ALCOHOLISM: CLINICAL UTILITY
Farren and Tipton
Alcohol Alcohol 1999;34:649-665.
ABSTRACT | FULL TEXT  

Naloxone Challenge in Smokers: Preliminary Evidence of an Opioid Component in Nicotine Dependence
Krishnan-Sarin et al.
Arch Gen Psychiatry 1999;56:663-668.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.